Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.

about

Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q38998632

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Y-box-binding protein 1 contri ...... acute lymphoblastic leukemia.

@en

type

Item

label

Y-box-binding protein 1 contri ...... acute lymphoblastic leukemia.

@en

prefLabel

Y-box-binding protein 1 contri ...... acute lymphoblastic leukemia.

@en

P1476

Y-box-binding protein 1 contri ...... r acute lymphoblastic leukemia

@en

P2093

Amina Kariminia

http://www.w3.org/2001/XMLSchema#string

Aru Narendran

http://www.w3.org/2001/XMLSchema#string

Jacob Rozmus

http://www.w3.org/2001/XMLSchema#string

Nicole Couto

http://www.w3.org/2001/XMLSchema#string

Sabine M Ivison

http://www.w3.org/2001/XMLSchema#string

Sandra E Dunn

http://www.w3.org/2001/XMLSchema#string

Susanna Sung

http://www.w3.org/2001/XMLSchema#string

Vivian M Leung

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Nuclear translocation of the Y-box binding protein by ultraviolet irradiation

Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells

Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.

Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia.

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species.

Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.

Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

YB-1 synthesis is regulated by mTOR signaling pathway.

P304

497-505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.5437

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kirk R Schultz

Nina Rolf

Gregor S Reid

P577

2016-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28123588

http://www.w3.org/2001/XMLSchema#string

P932

5244896

http://www.w3.org/2001/XMLSchema#string